Sara Mabrouk Mohamed Elghoul
Tanta, Egypt
NCT Number: NCT05912673
The use of the renal resistive index in pediatric patient with idiopathic nephrotic syndrome to detect steroid resistance and to use it as a prognostic instrument of the progression of the disease.
Looking for future studies?
Notify Me1 year–18 year
All sexes
Observational
Tanta, Egypt
Renal Doppler will be done for all children in supine and lateral positions using Toshiba Aplio ultrasound machine and renal resistive index will be measured (peak systolic velocity- end diastolic velocity/ peak systolic velocity) at diagnosis, after one month, 3 months and 6months, in which these values will be obtained by the ultrasound machine based on the computer algorithm. Also the kidneys will be scanned firstly for length, width, cortical thickness and echogenicity.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Toshiba Aplio ultrasound machine and renal resistive index will be measured (peak systolic velocity- end diastolic velocity/ peak systolic velocity
Time frame: 6 weeks
measurement of renal resistive index and detection of steroid sensitivity
Time frame: six months
frequent measurement of renal resistive index and using it as prognostic factor
Tanta University
Other
Renal Doppler in Detection of Steroid Resistance in Pediatric Patients With Idiopathic Nephrotic Syndrome
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07320612
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Lahore, Punjab Province, Pakistan
View Trial DetailsNCT02238418
Chronic Disease, Chronic Kidney Disease
Bron, France
View Trial DetailsNCT05904197
Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications
Al Mansurah, Egypt
View Trial DetailsNCT04850378
Autoimmune Diseases, Blood Protein Disorders
Aarhus, Denmark
View Trial Details